子宫腺肌病相关免疫变化:系统综述
本系统综述检索1970年至2019年2月MEDLINE、EMBASE和Cochrane Library数据库,纳入42项人类研究,探讨免疫系统在子宫腺肌病发生中的作用。研究发现,与无腺肌病对照相比,腺肌病患者在位和/或异位内膜中淋巴细胞和巨噬细胞数量增加,多种促炎和抗炎/调节性细胞因子升高,且免疫变化与孕激素受体异常及上皮间质转化(EMT)相关。
要点
- 腺肌病患者在位和异位内膜中淋巴细胞与巨噬细胞数量增加。
- 促炎因子(IL6、IL1β、IFNα、TNFα、IFNγ)及抗炎/调节因子(IL10、TGFβ等)在在位和/或异位内膜中升高。
- 免疫变化与孕激素受体异常及EMT相关,可能促进内膜细胞侵入肌层。
核心结论
- 文献清晰显示子宫腺肌病与全身及局部免疫变化相关,炎症与抗炎信号共存,可能通过EMT机制促进内膜细胞迁移并协同内分泌失衡推动疾病。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE和Cochrane Library数据库1970年至2019年2月发表的人类研究,最终纳入42篇文章。
主要发现
- 与无腺肌病对照相比,腺肌病在位和/或异位内膜中淋巴细胞和巨噬细胞数量增加。
- 三项研究报道免疫与性激素异常(尤其孕激素受体变化)直接或间接相关,四项研究报道免疫与EMT相关。
临床怎么用
- 临床可关注腺肌病患者局部和全身免疫微环境变化,以及孕激素受体和EMT相关通路。
局限性
- 纳入研究需与无腺肌病对照比较,排除无对照研究;检索截止2019年2月,可能未涵盖后续证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adenomyosis is a benign gynecological disorder associated with subfertility, pelvic pain and abnormal uterine bleeding that have significant consequences for the health and quality of life of women. Histologically, it is defined as the presence of ectopic endometrial islets within the myometrium. Its pathogenesis has not yet been elucidated and several pieces of the puzzle are still missing. One process involved in the development of adenomyosis is the increased capacity of some endometrial cells to infiltrate the myometrium. Moreover, the local and systemic immune systems are associated with the onset of the disease and with maintaining it. Numerous observations have highlighted the activation of immune cells and the release of immune soluble factors in adenomyosis. The contribution of immunity occurs in conjunction with hormonal aberrations and activation of the epithelial to mesenchymal transition (EMT) pathway, which promotes migration of endometrial cells. Here, we review current knowledge on the immunological changes in adenomyosis, with the aim of further elucidation of the pathogenesis of this disease. OBJECTIVE AND RATIONALE: The objective was to systematically review the literature regarding the role of the immune system in development of adenomyosis in the inner and the outer myometrium, in humans. SEARCH METHODS: A systematic review of published human studies was performed in MEDLINE, EMBASE and Cochrane Library databases from 1970 to February 2019 using the combination of Medical Subject Headings (MeSH): Adenomyosis AND ('Immune System' OR 'Gonadal Steroid Hormones'), and free-text terms for the following search terms (and their variants): Adenomyosis AND (immunity OR immune OR macrophage OR 'natural killer cell' OR lymphocyte* OR leucocyte* OR HLA OR inflammation OR 'sex steroid' OR 'epithelial to mesenchymal transition' OR 'EMT'). Studies in which no comparison was made with control patients, without adenomyosis (systemic sample and/or eutopic endometrium), were excluded. OUTCOMES: A total of 42 articles were included in our systematic review. Changes in innate and adaptive immune cell numbers were described in the eutopic and/or ectopic endometrium of women with adenomyosis compared to disease-free counterparts. They mostly described an increase in lymphocyte and macrophage cell populations in adenomyosis eutopic endometrium compared to controls. These observations underscore the immune contributions to the disease pathogenesis. Thirty-one cytokines and other markers involved in immune pathways were studied in the included articles. Pro-inflammatory cytokines (interleukin (IL) 6, IL1β, interferon (IFN) α, tumor necrosis factor α, IFNγ) as well as anti-inflammatory or regulatory mediators (IL10, transforming growth factor β…) were found to be elevated in the eutopic endometrium and/or in the ectopic endometrium of the myometrium in women with adenomyosis compared to controls. Moreover, in women affected by adenomyosis, immunity was reported to be directly or indirectly linked to sex steroid hormone aberrations (notably changes in progesterone receptor in eutopic and ectopic endometrium) in three studies and to EMT in four studies. WIDER IMPLICATIONS: The available literature clearly depicts immunological changes that are associated with adenomyosis. Both systemic and local immune changes have been described in women affected by adenomyosis, with the coexistence of changes in inflammatory as well as anti-inflammatory signals. It is likely that these immune changes, through an EMT mechanism, stimulate the migration of endometrial cells into the myometrium that, together with an endocrine imbalance, promote this inflammatory process. In light of the considerable impact of adenomyosis on women's health, a better understanding of the role played by the immune system in adenomyosis is likely to yield new research opportunities to better understand its pathogenesis.
引用
- Bourdon M, Santulli P, Jeljeli M, et al. Immunological changes associated with adenomyosis: a systematic review. Hum Reprod Update. 2021. PMID: 33099635. doi:10.1093/humupd/dmaa038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。